InVivo Therapeutics Holdings ROE 2006-2018 | NVIV

Current and historical return on equity (ROE) values for InVivo Therapeutics Holdings (NVIV) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. InVivo Therapeutics Holdings ROE for the three months ending September 30, 2018 was -292.02%.
InVivo Therapeutics Holdings ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $-0.03B $0.02B -305.88%
2018-06-30 $-0.03B $-0.00B -426.67%
2018-03-31 $-0.03B $0.01B -196.08%
2017-12-31 $-0.03B $0.01B -155.22%
2017-09-30 $-0.03B $0.01B -120.93%
2017-06-30 $-0.02B $0.02B -87.62%
2017-03-31 $-0.02B $0.02B -70.97%
2016-12-31 $-0.02B $0.03B -65.25%
2016-09-30 $-0.02B $0.03B -71.32%
2016-06-30 $-0.02B $0.04B -67.26%
2016-03-31 $-0.02B $0.04B -106.67%
2015-12-31 $-0.03B $0.02B -223.73%
2015-09-30 $-0.04B $0.02B -300.00%
2015-06-30 $-0.04B $0.02B -311.11%
2015-03-31 $-0.03B $0.01B -263.64%
2014-12-31 $-0.02B $0.01B -167.44%
2014-09-30 $-0.02B $0.01B -128.00%
2014-06-30 $-0.02B $0.01B -148.15%
2014-03-31 $-0.03B $0.01B -193.55%
2013-12-31 $-0.04B $0.01B -389.74%
2013-09-30 $-0.04B $0.02B -683.33%
2013-06-30 $-0.03B $0.02B -1018.18%
2013-03-31 $-0.01B $-0.01B 300.00%
2012-12-31 $0.00B $-0.00B -160.00%
2012-09-30 $-0.02B $0.01B 225.64%
2012-06-30 $-0.03B $-0.01B 240.00%
2012-03-31 $-0.03B $-0.01B 272.73%
2011-12-31 $-0.03B $-0.03B 348.72%
2011-09-30 $-0.01B $-0.00B 200.00%
2011-06-30 $-0.01B $-0.00B 400.00%
2011-03-31 $-0.01B $-0.00B 720.00%
2010-12-31 $-0.01B $-0.00B 1600.00%
2010-09-30 $-0.00B $0.00B inf%
2010-06-30 $-0.00B $0.00B inf%
2010-03-31 $0.00B $0.00B nan%
2009-12-31 $0.00B $0.00B nan%
2009-09-30 $0.00B $0.00B nan%
2009-06-30 $0.00B $0.00B nan%
2009-03-31 $0.00B $0.00B nan%
2008-12-31 $0.00B $0.00B nan%
2008-09-30 $0.00B $0.00B nan%
2008-06-30 $0.00B $0.00B nan%
2008-03-31 $0.00B $0.00B nan%
2007-12-31 $0.00B $0.00B nan%
2007-09-30 $0.00B $0.00B nan%
2007-06-30 $0.00B $0.00B nan%
2007-03-31 $0.00B $0.00B nan%
2006-12-31 $0.00B $0.00B nan%
2006-09-30 $0.00B $0.00B nan%
2006-06-30 $0.00B $0.00B nan%
2006-03-31 $0.00B $0.00B nan%
2005-12-31 $0.00B $0.00B nan%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.014B $0.000B
InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $138.463B 27.37
Medtronic (MDT) Ireland $123.238B 18.02
Stryker (SYK) United States $72.140B 26.48
Boston Scientific (BSX) United States $52.625B 25.66
Baxter (BAX) United States $39.440B 25.23
Zimmer Biomet Holdings (ZBH) United States $25.620B 16.40
Smith & Nephew SNATS (SNN) United Kingdom $17.350B 0.00
Canopy Growth (CGC) Canada $15.290B 0.00
ResMed (RMD) United States $13.957B 26.47
Aurora Cannabis (ACB) Canada $10.062B 71.00
Bio-Rad Laboratories (BIO) United States $9.398B 53.62
Hill-Rom Holdings (HRC) United States $6.885B 21.30
Perrigo (PRGO) Ireland $6.613B 10.72
Insulet (PODD) United States $5.778B 1949.40
GW Pharmaceuticals (GWPH) United Kingdom $5.086B 0.00
ICU Medical (ICUI) United States $4.899B 30.50
Haemonetics (HAE) United States $4.340B 38.50
Hutchison China MediTech (HCM) China $3.826B 0.00
Agios Pharmaceuticals (AGIO) United States $3.786B 0.00
Neogen (NEOG) United States $3.284B 50.45
NuVasive (NUVA) United States $2.842B 24.79
Quidel (QDEL) United States $2.668B 24.07
Aphria (APHA) $2.563B 113.78
National Vision Holdings (EYE) United States $2.360B 46.42
HEXO (HEXO) $1.416B 0.00
Cardiovascular Systems (CSII) United States $1.374B 986.50
Phibro Animal Health (PAHC) United States $1.297B 18.65
VAREX IMAGING (VREX) United States $1.256B 24.58
AtriCure (ATRC) United States $1.094B 0.00
Lantheus Holdings (LNTH) United States $0.953B 25.76
MacroGenics (MGNX) United States $0.931B 0.00
Cerus (CERS) United States $0.852B 0.00
NanoString Technologies (NSTG) United States $0.848B 0.00
Omeros (OMER) United States $0.819B 0.00
PetIQ (PETQ) United States $0.789B 22.59
OraSure Technologies (OSUR) United States $0.719B 31.51
Meridian Bioscience (VIVO) United States $0.695B 20.71
Eagle Pharmaceuticals (EGRX) United States $0.685B 23.30
TG Therapeutics (TGTX) United States $0.652B 0.00
Evolus (EOLS) United States $0.651B 0.00
Surmodics (SRDX) United States $0.641B 93.25
LeMaitre Vascular (LMAT) United States $0.620B 29.49
Quanterix (QTRX) United States $0.546B 0.00
BioLife Solutions (BLFS) United States $0.383B 157.77
Rockwell Medical (RMTI) United States $0.354B 0.00
Vapotherm (VAPO) United States $0.333B 0.00
Insys Therapeutics (INSY) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.312B 20.27
Owens & Minor (OMI) United States $0.283B 3.91
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.266B 0.00
Bovie Medical (APYX) United States $0.262B 0.00
Cytosorbents (CTSO) United States $0.252B 0.00
Surface Oncology (SURF) United States $0.144B 0.00
Fonar (FONR) United States $0.142B 7.60
Zynex (ZYXI) United States $0.140B 15.00
Chimerix (CMRX) United States $0.103B 0.00
Chembio Diagnostics (CEMI) United States $0.101B 0.00
Female Health (VERU) United States $0.090B 0.00
United-Guardian (UG) United States $0.089B 18.54
Conatus Pharmaceuticals (CNAT) United States $0.087B 0.00
InfuSystems Holdings (INFU) United States $0.086B 0.00
CAS Medical Systems (CASM) United States $0.072B 0.00
Trinity Biotech (TRIB) Ireland $0.072B 21.43
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00
Neurotrope (NTRP) United States $0.052B 0.00
Valeritas Holdings (VLRX) United States $0.038B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Senestech (SNES) United States $0.025B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
Myomo (MYO) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
NeuroMetrix (NURO) United States $0.008B 15.14